Breast Cancer

Enhertu significantly improved invasive disease-free survival when compared with Kadcyla in high-risk HER2-positive early breast cancer.

I faced breast cancer and unexpected body changes with resilience and humor, learning to adapt and find strength in the process.

As a metastatic breast cancer patient, I want to control what I can, including my diet and exercise.

The FDA granted priority review to an sBLA for first-line treatment with Enhertu plus Perjeta in unresectable or metastatic HER2-positive breast cancer.

I’ve lived 22 years beyond my breast cancer diagnosis, and each day I honor survival with gratitude, wellness, and hope for myself and others.

Going through breast cancer has pushed me to do things I never thought I would.

CURE spoke with Amanda Davis at the John Theurer Cancer Center in Hackensack, New Jersey.

CURE spoke with nurse and breast cancer survivor Amanda Davis at the John Theurer Cancer Center.

Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer.

Many of the choices I've made regarding yard maintenance relate to my hopes to mitigate the risk of more cancer.

A guide for patients to understand HER2-positive breast cancer, treatment options by stage and how to talk with your oncologist.

The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.

Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.

Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and has caused me to become more grateful.

Susan G. Komen is marking a significant milestone in the effort to improve care and outcomes for people facing inflammatory breast cancer (IBC).

Chemotherapy can trigger early menopause, while strategies and new data on pausing therapy may help women protect fertility and plan pregnancy.

When my daughter was diagnosed with breast cancer at 27, I watched her show courage through every treatment, side effect and moment of resolve.

For patients with HR+, HER2- early breast cancer, MammaPrint may predict distant recurrence-free interval prognosis and chemotherapy benefit.

The FDA has granted fast track designation to the cancer vaccine GLSI-100 for patients with HLA-A*02-positive and HER2-positive breast cancer.

When I think of fall, my mind jumps to when I had to wear furry hats because I’d lost my hair from chemotherapy.

The symbolism of seasons helped me to put some challenges of my cancer journey into perspective.

Leaving a legacy is essential for many, especially for those who have faced cancer. We long for our friends and family to understand how cancer impacts our lives.

As we head into Fall, I’ve been thinking about how much this season represents my daughter’s cancer experience for me.

Cancer taught me to embrace life’s seasons, finding hope, joy, and gratitude in each chapter, no matter the struggles I face.

Women with HR+ early breast cancer who paused endocrine therapy to become pregnant breastfed without increased risk of recurrence in the short term.